Novartis AG (NYSE:NVS)

89.52
BATS BZX Real-Time Price
As of 10:07am ET
 -1.03 / -1.14%
Today’s Change
79.34
Today|||52-Week Range
98.52
+2.34%
Year-to-Date
Dodge & Cox Global Stock Fund's 4th-Quarter Commentary
Jan 17 / GuruFocus News - Paid Partner Content
Where Will Biogen Be in 5 Years?
Jan 15 / MotleyFool.com - Paid Partner Content
Dodge & Cox Stock Fund's 4th-Quarter Commentary
Jan 17 / GuruFocus News - Paid Partner Content
Is electroCore a Good Stock to Add to Your Healthcare Portfolio?
Jan 14 / StockNews.com - Paid Partner Content
Glaxo (GSK) Rejects Unilever's $68B Bid for Consumer Business
Jan 17 / Zacks.com - Paid Partner Content
Molecular (MOLN), Novartis Post Positive Data From COVID-19 Drug
Jan 11 / Zacks.com - Paid Partner Content
GlaxoSmithKline - Catalysts Ahead
Jan 17 / GuruFocus News - Paid Partner Content
Why Molecular Partners Stock Crushed the Market Today
Jan 10 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy Right Now
Jan 15 / MotleyFool.com - Paid Partner Content
Novartis (NVS) Partners With Alnylam for Liver-Targeted Therapies
Jan 07 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close90.55
Today’s open89.53
Day’s range89.50 - 89.80
Volume295,055
Average volume (3 months)2,323,092
Market cap$202.6B
Data as of 10:07am ET, 01/18/2022

Growth & Valuation

Earnings growth (last year)+15.34%
Earnings growth (this year)-92.09%
Earnings growth (next 5 years)+6.89%
Revenue growth (last year)+2.44%
P/E ratio20.7
Price/Sales4.46
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.19-0.23%
AZNAstraZeneca+0.55+0.93%
LLYEli Lilly and Co+1.08+0.44%
NVONovo Nordisk-0.13-0.13%
Data as of 10:07am ET, 01/18/2022

Financials

Next reporting dateApril 26, 2022
EPS forecast (this quarter)$1.43
Annual revenue (last year)$48.7B
Annual profit (last year)$8.1B
Net profit margin16.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts